{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T08:16:01Z","timestamp":1765354561819,"version":"3.41.0"},"reference-count":0,"publisher":"International Institute of Anticancer Research","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IV"],"published-print":{"date-parts":[[2018,5,2]]},"DOI":"10.21873\/invivo.11292","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T07:53:07Z","timestamp":1525247587000},"source":"Crossref","is-referenced-by-count":8,"title":["Clinical Significance of the Neutrophil\u2013to\u2013Lymphocyte Ratio in Endocrine Therapy for Stage IV Breast Cancer"],"prefix":"10.21873","volume":"32","member":"9336","container-title":["In Vivo"],"original-title":[],"deposited":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T07:53:34Z","timestamp":1525247614000},"score":1,"resource":{"primary":{"URL":"http:\/\/iv.iiarjournals.org\/content\/32\/3\/669.abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,2]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,5,2]]}},"URL":"https:\/\/doi.org\/10.21873\/invivo.11292","relation":{},"ISSN":["1791-7549"],"issn-type":[{"type":"electronic","value":"1791-7549"}],"subject":[],"published":{"date-parts":[[2018,5,2]]}}}